About Implanet
Implanet is a company based in Martillac (France) founded in 2007. Implanet has raised $9.57 million across 2 funding rounds from investors including Edmond de Rothschild, CM-CIC Capital Prive and Wellington Partners Venture Capital. Implanet has completed 1 acquisition, including Orthopaedic & Spine Development. Implanet offers products and services including Rachis and Matériel chirurgical. Implanet operates in a competitive market with competitors including Globus Medical, RTI Surgical, DJO Global, OMNILife Sciences and Medacta International, among others.
- Headquarter Martillac, France
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Implanet Sa
-
Annual Revenue
$9.78 M (USD)26.31as on Dec 31, 2024
-
Net Profit
-$4.54 M (USD)34.6as on Dec 31, 2024
-
EBITDA
-$3.92 M (USD)22.25as on Dec 31, 2024
-
Total Equity Funding
$9.57 M (USD)
in 2 rounds
-
Latest Funding Round
$2.04 M (USD), Post-IPO
Nov 02, 2017
-
Investors
Edmond de Rothschild
& 4 more
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Implanet
Implanet is a publicly listed company on the EURONEXT with ticker symbol ALIMP in France, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Implanet
Implanet offers a comprehensive portfolio of products and services, including Rachis and Matériel chirurgical.
Medical devices for spine surgical procedures and support
Tools for various surgical applications and innovations
Funding Insights of Implanet
Implanet has successfully raised a total of $9.57M across 2 strategic funding rounds. The most recent funding activity was a Post-IPO round of $2.04 million completed in November 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Implanet
Implanet has secured backing from 5 investors, including venture fund investors. Prominent investors backing the company include Edmond de Rothschild, CM-CIC Capital Prive and Wellington Partners Venture Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm focused on SMEs
|
Locked | Locked | Locked | |
|
Investments are made in early-stage healthcare startups.
|
Locked | Locked | Locked | |
|
Diversified asset management, corporate advisory, and private equity firm focused on multiple sectors
|
Locked | Locked | Locked |
Investor details for Implanet
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Implanet
Implanet has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Orthopaedic & Spine Development.
Investment portfolio details for Implanet
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Implants for spine and extremities surgery are developed and distributed.
|
Locked | Locked | 2005 | Locked |
Complete acquisition details for Implanet
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Implanet
Detailed financials for Implanet
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Implanet Comparisons
Peer comparison for Implanet
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Implanet
Implanet operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Globus Medical, RTI Surgical, DJO Global, OMNILife Sciences and Medacta International, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of minimally invasive products for musculoskeletal procedures
|
|
| Locked | Locked | Locked |
Develops innovative technologies for spinal and orthopedic implants and instruments.
|
|
| Locked | Locked | Locked |
Orthopedic devices and pain management products are developed.
|
|
| Locked | Locked | Locked |
Hip and knee orthopedic implants are engineered, manufactured, and distributed.
|
|
| Locked | Locked | Locked |
Orthopedic implants and surgical instruments are manufactured for joint surgeries.
|
Detailed competitors of Implanet
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Implanet
Complete news archive for Implanet
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Implanet
Implanet was founded in 2007 and raised its 1st funding round 3 years after it was founded.
Implanet is headquartered in Martillac, France. It is registered at Martillac, Gironde, France.
Implanet is a funded company, having raised a total of $9.57M across 2 funding rounds to date.
Annual revenue of Implanet is $9.78M as on Dec 31, 2024.
Implanet was founded in 2007 and is headquartered in Martillac, France. Orthopedic implants are developed by the company for surgical applications, including spine stabilization with systems like JAZZ and HAKA-PLIF for fracture consolidation or spinal correction in mature patients. Knee prostheses such as Madison are manufactured, alongside arthroscopy tools including Quick-Step, Paso Wire, Twist Buttons, and screws. Operations focus on medical device production within the healthcare sector.
Implanet's top competitors include Globus Medical, ExacTech and Medacta International.
Implanet offers Rachis and Matériel chirurgical.
Yes, Implanet is publicly traded on EURONEXT under the ticker symbol ALIMP.
Implanet has made 1 acquisition, including Orthopaedic & Spine Development.
Implanet has 5 investors. Key investors include Edmond de Rothschild, CM-CIC Capital Prive, Wellington Partners Venture Capital, Auriga Partners, and Seventure Partners.
The ticker symbol of Implanet is ALIMP on EURONEXT.